399 related articles for article (PubMed ID: 15466649)
21. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium.
Saraiva RM; Minhas KM; Raju SV; Barouch LA; Pitz E; Schuleri KH; Vandegaer K; Li D; Hare JM
Circulation; 2005 Nov; 112(22):3415-22. PubMed ID: 16301341
[TBL] [Abstract][Full Text] [Related]
23. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.
Dawson D; Lygate CA; Zhang MH; Hulbert K; Neubauer S; Casadei B
Circulation; 2005 Dec; 112(24):3729-37. PubMed ID: 16344403
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
Wang Y; Ahmad N; Wani MA; Ashraf M
J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
[TBL] [Abstract][Full Text] [Related]
25. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.
Maekawa Y; Anzai T; Yoshikawa T; Sugano Y; Mahara K; Kohno T; Takahashi T; Ogawa S
J Am Coll Cardiol; 2004 Oct; 44(7):1510-20. PubMed ID: 15464336
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of exercise training after myocardial infarction require full eNOS expression.
de Waard MC; van Haperen R; Soullié T; Tempel D; de Crom R; Duncker DJ
J Mol Cell Cardiol; 2010 Jun; 48(6):1041-9. PubMed ID: 20153335
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction.
Frantz S; Hu K; Widder J; Bayer B; Witzel CC; Schmidt I; Galuppo P; Strotmann J; Ertl G; Bauersachs J
Br J Pharmacol; 2004 Jan; 141(1):9-14. PubMed ID: 14662734
[TBL] [Abstract][Full Text] [Related]
28. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
Tsuneyoshi H; Nishina T; Nomoto T; Kanemitsu H; Kawakami R; Unimonh O; Nishimura K; Komeda M
Circulation; 2004 Sep; 110(11 Suppl 1):II174-9. PubMed ID: 15364859
[TBL] [Abstract][Full Text] [Related]
29. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
Soeki T; Kishimoto I; Okumura H; Tokudome T; Horio T; Mori K; Kangawa K
J Am Coll Cardiol; 2005 Feb; 45(4):608-16. PubMed ID: 15708711
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
31. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats.
Nakamura R; Kato J; Kitamura K; Onitsuka H; Imamura T; Cao Y; Marutsuka K; Asada Y; Kangawa K; Eto T
Circulation; 2004 Jul; 110(4):426-31. PubMed ID: 15262849
[TBL] [Abstract][Full Text] [Related]
32. Biglycan is required for adaptive remodeling after myocardial infarction.
Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
34. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice.
Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Tsutsui H; Kaibuchi K; Takeshita A
Circulation; 2004 May; 109(18):2234-9. PubMed ID: 15096457
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction.
Ikeuchi M; Matsusaka H; Kang D; Matsushima S; Ide T; Kubota T; Fujiwara T; Hamasaki N; Takeshita A; Sunagawa K; Tsutsui H
Circulation; 2005 Aug; 112(5):683-90. PubMed ID: 16043643
[TBL] [Abstract][Full Text] [Related]
36. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress.
Kinugawa S; Tsutsui H; Hayashidani S; Ide T; Suematsu N; Satoh S; Utsumi H; Takeshita A
Circ Res; 2000 Sep; 87(5):392-8. PubMed ID: 10969037
[TBL] [Abstract][Full Text] [Related]
37. Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat.
Mouquet F; Rousseau D; Domergue-Dupont V; Grynberg A; Liao R
Fundam Clin Pharmacol; 2010 Aug; 24(4):469-76. PubMed ID: 20030737
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage.
Hayakawa K; Takemura G; Kanoh M; Li Y; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Fujiwara T; Fujiwara H
Circulation; 2003 Jul; 108(1):104-9. PubMed ID: 12821555
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
[TBL] [Abstract][Full Text] [Related]
40. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
